CYCLOPHOSPHAMIDE MONOHYDRATE, VINORELBINE, Tecentriq 840 mg concentrate for solution for infusion
Phase 2 small_molecule active
Quick answer
CYCLOPHOSPHAMIDE MONOHYDRATE, VINORELBINE, Tecentriq 840 mg concentrate for solution for infusion for Inoperable locally advanced or metastatic TNBC patients, previously treated with anti-PD-L1/PD1- regimens is a Phase 2 program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Istituto Gentili S.r.l.
- Indication
- Inoperable locally advanced or metastatic TNBC patients, previously treated with anti-PD-L1/PD1- regimens
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active